HPS Pharmacies wish to give notice that Pfizer Australia are currently experiencing an interruption to the supply of:
Synarel® Nasal Spray
nafarelin (as acetate) 2mg/mL
Aust R. 48127
The supply interruption is due to manufacturing difficulties which could mean a delay of new stock until late June 2015. The shortage does not affect the safe use of products currently available in Australia.
Whilst no equivalent medicine is registered in Australia, HPS Pharmacies are pleased to advise that our current stock holdings are expected to meet the needs of clients and patients until normal supplies resume.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Pfizer Australia on 1800 675 229.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.